The key finding of our study is that inhibition of caspase-2 by TRIM25 constitutes a so far unrecognized pathway, which may be relevant for the resistance of human colon carcinoma cells to chemotherapy-induced apoptosis. Here, TRIM25 is linked to colon carcinoma.